Delineating the angiogenic gene expression profile before pulmonary vascular remodeling in a lamb model of congenital heart disease.
Disordered angiogenesis is implicated in pulmonary vascular remodeling secondary to congenital heart diseases (CHD). However, the underlying genes are not well delineated. We showed previously that an ovine model of CHD with increased pulmonary blood flow (PBF, Shunt) has an "angiogenesis burst" between 1 and 4 wk of age. Thus we hypothesized that the increased PBF elicited a proangiogenic gene expression profile before onset of vessel growth. To test this we utilized microarray analysis to identify genes that could be responsible for the angiogenic response. Total RNA was isolated from lungs of Shunt and control lambs at 3 days of age and hybridized to Affymetrix gene chips for microarray analyses (n = 8/group). Eighty-nine angiogenesis-related genes were found to be upregulated and 26 angiogenesis-related genes downregulated in Shunt compared with control lungs (cutting at 1.2-fold difference, P < 0.05). We then confirmed upregulation of proangiogenic genes FGF2, Angiopoietin2 (Angpt2), and Birc5 at mRNA and protein levels and upregulation of ccl2 at mRNA level in 3-day Shunt lungs. Furthermore, we found that pulmonary arterial endothelial cells (PAEC) isolated from fetal lambs exhibited increased expression of FGF2, Angpt2, Birc5, and ccl2 and enhanced angiogenesis when exposed to elevated shear stress (35 dyn/cm²) compared with cells exposed to more physiological shear stress (20 dyn/cm²). Finally, we demonstrated that blocking FGF2, Angpt2, Birc5, or ccl2 signaling with neutralizing antibodies or small interfering RNA (siRNA) significantly decreased the angiogenic response induced by shear stress. In conclusion, we have identified a "proangiogenic" gene expression profile in a lamb model of CHD with increased PBF that precedes onset of pulmonary vascular remodeling. Our data indicate that FGF2, Angpt2, Birc5, and ccl2 may play important roles in the angiogenic response.
Tian
Jing
J
Vascular Biology Center, Augusta, Georgia 30912, USA.
Fratz
Sohrab
S
Hou
Yali
Y
Lu
Qing
Q
Görlach
Agnes
A
Hess
John
J
Schreiber
Christian
C
Datar
Sanjeev A
SA
Oishi
Peter
P
Nechtman
John
J
Podolsky
Robert
R
She
Jin-Xiong
JX
Fineman
Jeffrey R
JR
Black
Stephen M
SM
D042702:Angiopoietin-2 / Q000235:genetics / Q000378:metabolism; D000818:Animals; D015153:Blotting, Western; D018932:Chemokine CCL2 / Q000235:genetics / Q000378:metabolism; D004195:Disease Models, Animal; D015536:Down-Regulation / Q000235:genetics; D042783:Endothelial Cells / Q000378:metabolism; D016222:Fibroblast Growth Factor 2 / Q000235:genetics / Q000378:metabolism; D020869:Gene Expression Profiling; D006331:Heart Diseases / Q000151:congenital* / Q000235:genetics* / Q000473:pathology / Q000503:physiopathology; D006439:Hemodynamics / Q000502:physiology; D008168:Lung / Q000098:blood supply* / Q000503:physiopathology*; D008869:Microtubule-Associated Proteins / Q000235:genetics / Q000378:metabolism; D018919:Neovascularization, Physiologic / Q000235:genetics*; D010641:Phenotype; D011651:Pulmonary Artery / Q000473:pathology; D011652:Pulmonary Circulation / Q000235:genetics*; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D015203:Reproducibility of Results; D020133:Reverse Transcriptase Polymerase Chain Reaction; D012756:Sheep; D013314:Stress, Mechanical; D015854:Up-Regulation / Q000235:genetics
D042702:Angiopoietin-2; D018932:Chemokine CCL2; D008869:Microtubule-Associated Proteins; D012333:RNA, Messenger; D016222:Fibroblast Growth Factor 2